Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

The Epidemic of the 20th Century: Coronary Heart Disease

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Bleeding Toes in Diabetic Neuropathy

Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C

Sexuality The American Journal of Medicine

Role of the CHADS2 Score in Acute Coronary Syndromes

Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Characteristics of Hospitalized Patients with Atrial Fibrillation in Taiwan: A Nationwide Observation Cheng-Han Lee, MD, Ping-Yen Liu, MD, PhD, Liang-Miin.

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Bleeding Toes in Diabetic Neuropathy

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Eric L. Eisenstein, DBA, Darren K. McGuire, MD, MHS, Manjushri V

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

A Population-Based Analysis of Outcomes in Patients With a Primary Diagnosis of Hypertension in the Emergency Department Sameer Masood, MD, Peter C.

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials Giulia Renda, MD, PhD, Marta.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

The Epidemic of the 20th Century: Coronary Heart Disease

Carotid Sinus Massage in Patients with Suspected Acute Myocardial Infarction, Tachycardia, and Left Bundle Branch Block Teddy Weiss, MD, Yair Elitzur,

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Osteoporotic Fractures and Heart Failure in the Community

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction Sripal Bangalore, MD, MHA, Gregg.

Differences in the Clinical Features and Outcomes in African Americans and Whites with Myocardial Infarction Rajendra H. Mehta, MD, MS, David Marks,

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Renato D. Lopes, MD, MHS, PhD, Meena Rao, MD,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

TIA for the Internist The American Journal of Medicine

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis G. Caleb Alexander, MD, MS, Geetha Iyer, MBBS, Eleanor.

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

When Guidelines Cause Hypertension

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Molly E. Waring, PhD, Jane S

John P. Vavalle, MD, MHS, Renato D. Lopes, MD, PhD, Anita Y

Yader Sandoval, MD, Stephen W. Smith, MD, Sara A

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Devraj Sukul, MD, Shashank S. Sinha, MD, MSc, Andrew M

National Trends in Ambulatory Oral Anticoagulant Use

Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes John A. Dodson, MD, Tuyet-Trinh N. Truong,

Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy Jacques Donzé, MD, MSc, Carole Clair, MSc, MD, Balthasar Hug, MD, MBA, MPH,

Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

Has mortality from acute renal failure decreased

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

William S. Jenkins, MB, BCh, Véronique L. Roger, MD, MPH, Allan S

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Presentation transcript:

Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B. Granger, MD, Tracy Y. Wang, MD, MHS, MSc, JoAnne M. Foody, MD, Marjorie Funk, PhD, RN, Eric D. Peterson, MD, MPH, Karen P. Alexander, MD The American Journal of Medicine Volume 125, Issue 9, Pages 897-905 (September 2012) DOI: 10.1016/j.amjmed.2012.04.006 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Use of discharge antithrombotic therapy among patients with atrial fibrillation by CHADS2 score. CHADS2=Congestive heart failure, Hypertension, Age, Diabetes, Stroke (Doubled). The American Journal of Medicine 2012 125, 897-905DOI: (10.1016/j.amjmed.2012.04.006) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Use of discharge antithrombotic therapy among patients with atrial fibrillation by bleeding score at discharge. The American Journal of Medicine 2012 125, 897-905DOI: (10.1016/j.amjmed.2012.04.006) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Use of discharge warfarin and triple therapy among patients with atrial fibrillation according to CHADS2 score. CHADS2=Congestive heart failure, Hypertension, Age, Diabetes, Stroke (Doubled). The American Journal of Medicine 2012 125, 897-905DOI: (10.1016/j.amjmed.2012.04.006) Copyright © 2012 Elsevier Inc. Terms and Conditions